Format

Send to

Choose Destination
See comment in PubMed Commons below
Presse Med. 2006 Oct;35(10 Pt 2):1557-63.

[Hormone replacement therapy in the management of postmenopausal osteoporosis and prevention of fracture risk].

[Article in French]

Author information

1
Unité ménopause et maladies osseuses métaboliques, Hôpital Paule de Viguier, Toulouse (31). ribot.c@chu-toulouse.fr

Abstract

The consequences to the bone of estrogen deficiency are early and irreversible. Effective prevention of postmenopausal osteoporosis at the individual level requires early screening of women at risk of fractures and their early treatment. Hormone treatment prevents bone loss and has been proven effective in preventing fractures, even in situations of low risk. The benefit/risk ratio of hormone treatment can be optimized by the choice of the 'right moment' and the 'right treatment'. HRT, administered early and for a limited period, must be integrated into a strategy of long-term osteoporosis prevention that includes using the (drug and nondrug) means most appropriate to the patient's age and clinical condition and choosing the 'right moment' and 'right treatment.'

PMID:
17028521
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center